NICE
UK's NICE Expands Tumor Profiling Recommendations for Guiding Adjuvant Chemo in Early Breast Cancer
Previously, NICE recommended EndoPredict, Prosigna, and Oncotype DX for node-negative breast cancer only, but the new guidance includes lymph node-positive disease.
In Brief This Week: NICE; DHA; MDxHealth; Bionano; Devyser; Gradientech
News items for the week of Aug. 21, 2023.
NICE Committee Recommends Fecal Testing for All Patients With Signs of Colorectal Cancer
Offering fecal immunochemical tests to all patients with signs of the disease is expected to reduce the number of unnecessary colonoscopies.
UK's NICE Recommends Genetic Testing for Therapy Selection in Stroke Patients
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
NICE Recommends Genedrive Test in Draft Guidance to Prevent Hearing Loss in Newborns
NICE recommended that Genedrive's MT-RNR1 ID Kit should be adopted by the NHS for the prevention of antibiotic-induced hearing loss.